Patents
Patents for C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
08/2006
08/01/2006US7084150 pain therapy, transdermal application
07/2006
07/27/2006US20060167258 Production of opioid analgesics
07/13/2006WO2006073396A1 Analgesic conjugates
07/13/2006US20060155130 Method for the catalytic production of hydrocodone, hydromorphone, and derivatives thereof
07/13/2006CA2593165A1 Analgesic conjugates
07/12/2006CN1263760C Novel buprenorphine ester derivatives and process for preparing the same and medical composition with long-acting analgesic effect
07/11/2006CA2244256C Antipruritic
07/04/2006US7071336 Process for manufacturing opioid analgesics
07/04/2006CA2233285C Pyrazolopyrimidines as crf receptor antagonists
06/2006
06/29/2006WO2006066362A1 Methods of treating pain
06/29/2006US20060142320 Polymorphic forms of naltrexone
06/29/2006CA2592407A1 Methods of treating pain
06/22/2006WO2006064779A1 Indolomorphinan derivative having carboxy in 6'-position
06/22/2006WO2005047291A9 Method for the catalytic production of hydrocodone and hydromorphone
06/22/2006CA2590182A1 Indolomorphinan derivatives having carboxy at the 6'-position
06/08/2006DE10081928B4 6-O-Acetylmorphin (6MAM)-Analoge Verbindungen, welche zur Verwendung in Immuntests geeignet sind, hiergegen gewonnene Antikörper, deren Herstellung sowie Reagentien und Reagenssysteme, die diese umfassen 6-O-acetylmorphine (6MAM) analogs compounds which are suitable for use in immunoassays, antibody obtained against this, their preparation as well as reagents and reagent systems which comprise these
06/07/2006EP1664061A1 Process for the synthesis of morphinane compounds and intermediates thereof
05/2006
05/31/2006EP1660088A2 Pyridomorphinans, pyridazinomorphinans and use thereof
05/26/2006WO2005113557A8 Method for the catalytic production of hydrocodone and hydromorphone
05/25/2006US20060111383 Preparing a mixture comprising oxycodone and a solvent, adjusting the pH of the mixture to less than 6 and heating the mixture at the temperature of at least 55 degrees C for a period of at least 1 hour; and subsequently; exposing the mixture to hydrogenation reagents
05/25/2006US20060111381 Amidine compounds
05/24/2006EP1658293A1 A method of preparation of oxycodone
05/24/2006EP1485051A4 Method of administering buprenorphine to treat depression
05/23/2006CA2189140C New antagonist compounds
05/18/2006WO2006052456A1 Method for separation and purification of hydrocodone by preparative chromatography
05/18/2006CA2585533A1 Method for separation and purification of hydrocodone by preparative chromatography
05/11/2006WO2006049248A1 Analgesic
05/04/2006WO2005077957A3 Methods for making 3-o-protected morphinones and 3-o-protected morphinone dienol carboxylates
05/04/2006US20060094741 Remedies for neuropathic pain and model animals of neuropathic pain
05/02/2006CA2191843C The preparation of nalbuphine having low levels of beta-epimer
04/2006
04/12/2006CN1758912A Therapeutic agents for drug/substance dependence
04/11/2006US7026134 Contacting the sample with the conjugate and an antibody capable of binding atleast one epitope of oxycodone and its metabolite, and detecting the bound conjugate
04/06/2006WO2006035195A1 Preparation of opiate analgesics by reductive alkylation
04/06/2006US20060074239 Method for the catalytic production of hydrocodone and hydromorphone
04/04/2006US7022724 Cognition enhancing derivatives of isoxazole triazoloindane GABA-A α5 receptor subunit ligands
03/2006
03/30/2006WO2006034039A2 Substituted morphinans and methods of their use
03/30/2006CA2597410A1 Substituted morphinans and methods of their use
03/29/2006EP1638975A2 Method for preparing oxycodone
03/23/2006US20060063792 Substituted morphinans and methods of their use
03/16/2006WO2006029167A2 Treatment of diseases using nalmefene and its analgos
03/16/2006CA2579378A1 Treatment of diseases using nalmefene and its analogs
03/14/2006CA2380810C Pyridomorphinans and use thereof
03/14/2006CA2241014C Morphine derivatives with analgesic activity
03/07/2006US7008939 Use of weak opioids and mixed opioid agonists/antagonists for treatment of urinary incontinence
03/02/2006US20060047119 Analgesics with use of treating pain and as immunomodulators and for treatment of drug dependence
03/01/2006EP1628664A2 Polymorphic forms of naltrexone
02/2006
02/28/2006CA2144770C Brain cell protective agent
02/23/2006US20060040970 Administering 4,5 alpha -epoxy-6 beta -(3,4-dihydro-2H-benzo[1,4]thiazino)-3-methoxy-17-methyl-morphinan; for urinary frequency, therapeutic or prophylactic effect and of which side effects are improved
02/09/2006US20060030580 Contacting phenolic piperidines with opioid receptors; analgesics, anticonvulsants, antitussive agents; diarrhea, drug addiction
02/08/2006EP1623703A1 Controlled release hydrocodone formulations
02/02/2006US20060025434 Therapeutic agents for drug/substance dependence
01/2006
01/24/2006CA2143864C Morphinan derivatives and pharmaceutical use thereof
01/19/2006US20060014771 Quaternizing a tertiary N-substituted morphinan alkaloid substrate such as naltrexone with an alkylating agent such as methyl bromide in an anhydrous aprotic dipolar solvent; separating a 3-alkoxymorphinan from a 3-hydroxymorphinan by forming a salt of the hydride with a strong base and precipitating it.
01/12/2006US20060009479 Process for the synthesis of hydromorphone
01/11/2006CN1720232A Tetandrine and tetrandrine compound, synthesis and application
01/05/2006WO2005009377A3 Novel oral bioavailable prodrugs
12/2005
12/29/2005WO2005123743A1 Extraction of alkaloids from opium
12/29/2005CA2569758A1 Extraction of alkaloids from opium
12/28/2005EP1368023B1 Utilization of buprenorphine in urinary incontinence therapy
12/28/2005EP1053238B1 Therapeutic compounds
12/28/2005CN1233645C Novel oripavine derivative and its medical use
12/21/2005CN1711270A Process for the preparation of quaternary n-alkyl morphinan alkaloid salts
12/15/2005WO2005117589A1 Synthesis of metabolically stable analgesics, pain medications and other agents
12/15/2005CA2568249A1 Synthesis of metabolically stable analgesics, pain medications and other agents
12/07/2005EP1602374A1 Remedy for drug/substance dependence
12/06/2005US6972332 Process for the production of opiates
12/01/2005WO2005113557A1 Method for the catalytic production of hydrocodone and hydromorphone
12/01/2005CA2544950A1 Method for the catalytic production of hydrocodone and hydromorphone
11/2005
11/30/2005CN1703416A Methods and compositions comprising nitric oxide donors and opioid analgesics
11/30/2005CN1703415A Remedies or preventives for urinary frequency or urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group
11/29/2005CA2247616C Morphine and diamorphine salts of anionic non-narcotic analgesics of the substituted carboxylic acid type
11/24/2005US20050261500 methylating morphine in inert solvent in presence of alkaline ingedient, then recovering codeine as free base
11/24/2005US20050261329 administering morphinan's such as 3-methoxy-17-allylmorphinan hydrobromide for prevention or treatment of viral infections, septic shock, organ damage, neurological and cardiovascular disorders, neurodegenerative diseases and cancers
11/23/2005EP1467718B1 Method of treatment of a patient requiring analgesia
11/22/2005CA2304722C Acidic addition salts of morphine alkaloids and the application thereof
11/22/2005CA2261675C Preparation of narcotic analgesics
11/02/2005CN1692117A Preparation of codeine from morphine
10/2005
10/27/2005WO2005100361A1 A METHOD OF PREPARATION OF 4,5α-EPOXY-6-OXOMORPHINAN DERIVATIVES
10/27/2005WO2005100357A1 Mitotic kinesin inhibitors
10/27/2005CA2561904A1 Mitotic kinesin inhibitors
10/26/2005EP1504011B1 Microbial n- and o-demethylation of a thebaine derivative
10/25/2005US6958398 Methods for making thebaine or its acid salts
10/20/2005WO2005097801A1 Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
10/20/2005CA2774121A1 Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
10/20/2005CA2557845A1 Process for preparing, and composition and pharmaceutical dosage forms containing, an oxycodone salt having less than 25 ppm 14-hydroxycodeinone
10/19/2005CN1684967A N-substituted hydromorphones and the use thereof
10/13/2005WO2005094826A1 Anti-itching agent
10/13/2005US20050228002 Anti proliferavtive agents; small molecule inhibitors of KSP(kinesin-related proteins); N-(3-aminopropyl)-N-[1-(3-benzyl-4-oxo-6,7,8 ,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-2-yl)propyl]-4-bromobenzamide
10/06/2005US20050222188 comprising hydrogenating with a hydrogen donor and a catalyst under reflux
09/2005
09/29/2005US20050215556 Macrocyclic kinase inhibitors
09/28/2005CN1675217A Oxycodone-hydrochloride polymorhs
09/27/2005US6949645 methylation morphine using phenyltrimethylammonium chloride as alkylation agents, in the presence of inorganic phosphates, to form codeine or oripavine; purity; efficiency
09/22/2005WO2005086960A2 Narcotic-nsaid ion pairs
09/20/2005US6946556 Preparation of opioid analgesics by a one-pot process
09/15/2005US20050203115 Narcotic-NSAID ion pairs
09/07/2005CN1665819A Morphinan derivatives the quaternary ammonium salts thereof substituted in position 14, method for production and use thereof
09/01/2005US20050192308 N-but-E-enyl norbuprenorphine and methods of use
08/2005
08/25/2005WO2005077957A2 Methods for making 3-o-protected morphinones and 3-o-protected morphinone dienol carboxylates
08/25/2005CA2808199A1 Methods for making 3-o-protected morphinones and 3-o-protected morphinone dienol carboxylates
08/18/2005US20050182258 Morphinan derivatives the quaternary ammonium salts thereof substituted in position 14, method for production and use thereof
1 ... 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24